Tekla Capital Management LLC Merus N.V. Transaction History

Tekla Capital Management LLC

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 10, 2023	SELL	$14.25 - $20.5 $332,025 - $477,650	-23,300 Reduced 25.24%	69,025 $1.27 Million
Q4 2022 Feb 10, 2023	SELL	$12.8 - $23.66 $984,089 - $1.82 Million	-76,882 Reduced 45.44%	92,325 $1.43 Million
Q3 2022 Nov 01, 2022	BUY	$18.64 - $28.93 $1.38 Million - $2.14 Million	73,917 Added 77.57%	169,207 $3.39 Million
Q1 2022 May 13, 2022	BUY	$23.58 - $30.91 $1.26 Million - $1.65 Million	53,433 Added 127.66%	95,290 $2.52 Million
Q4 2021 Feb 14, 2022	BUY	$20.0 - $32.29 $837,140 - $1.35 Million	41,857 New	41,857 $1.33 Million
Q2 2020 Aug 13, 2020	SELL	$10.5 - $17.36 $222,757 - $368,292	-21,215 Closed	0 $0
Q4 2019 Feb 13, 2020	SELL	$14.08 - $18.5 $2,900 - $3,811	-206 Reduced 0.96%	21,215 $299,000
Q3 2019 Nov 13, 2019	SELL	$14.55 - $20.52 $3.25 Million - $4.59 Million	-223,693 Reduced 91.26%	21,421 $382,000
Q2 2019 Aug 14, 2019	SELL	$12.93 - $16.83 $938,162 - $1.22 Million	-72,557 Reduced 22.84%	245,114 $3.59 Million
Q1 2019 May 14, 2019	SELL	$11.09 - $15.83 $554,500 - $791,500	-50,000 Reduced 13.6%	317,671 $4.69 Million
Q4 2018 Feb 13, 2019	SELL	$11.46 - $20.81 $532,248 - $966,499	-46,444 Reduced 11.22%	367,671 $5.15 Million
Q2 2018 Aug 13, 2018	SELL	$16.77 - $22.76 $1.09 Million - $1.48 Million	-65,035 Reduced 13.57%	414,115 $9.43 Million
Q2 2017 Aug 14, 2017	BUY	N/A	479,150	479,150 $7.6 Million

200

61.9M

243K

300K

Ticker MRUS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 45,878,200
Market Cap $2.28B
Description
Merus N.V., a clinical-stage immuno-oncology company, engages in the discovery and development of bispecific antibody therapeutics in the Netherlands. Its bispecific antibody candidate pipeline includes Zenocutuzumab (MCLA-128), which is in a phase 2 clinical trials for the treatment of patients with metastatic breast cancer, as well as in Phase...

Get notified when there are updates to the investment portfolio of Tekla Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Tekla Capital Management LLC with notifications on news.